NANOMNIA Overview
With a focus on improving drug delivery, the company uses nano-encapsulation to shield drugs from degradation, to target specific biological tissues, to bypass certain barriers and deliver limited harm to the organisms, being they humans, plants or animals. Nanomnia offers its technology to chemical companies in the field of pharma, agritech, cosmetics and nutraceuticals, needing to improve the efficiency of their products. The service of organic encapsulation technology provides full compliance with recent EU REACH update laws (January 2019), which restrict the use of chemicals and microplastics in agriculture treatments. Moreover, COGS (costs of goods sold) related to raw materials are ten times lower, on average. Unlike synthetic approaches currently used, not fully biodegradable in the environment, Nanomnia employes only organic, naturally derived polymers for encapsulation, allowing lower impact, higher specificity of treatment, and cost savings of raw materials.
Latest News
No news articles.
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | — |
| Rounds | — |
| Investors | — |
Team Members
0
Web & Social Links
| Website | nanomnia.eu |
Photos & Videos
No files yet
NANOMNIA Business
Sector
—Target Customer
—Core Technology
—NANOMNIA Financials
NANOMNIA Lifecycle
NANOMNIA News
0 articlesNo news articles.
NANOMNIA Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
NANOMNIA Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 97/100 |
| Missing | video or image, news, markets |
| Last update | 2020-02-11T00:00:00.000Z |
| Claimed | Yes |
| Hidden | Pending approval (visible: 0) |